Extracellular matrix protein lumican regulates inflammation in a mouse model of colitis

Inflammatory Bowel Diseases

Volumn 18, Issue 1, 2012, Pages 143-151

  Lohr, Kristin ^a   Sardana, Hardik ^b   Lee, Seakwoo ^a   Wu, Feng ^c   Huso, David L ^a   Hamad, Abdel Rahim ^a   Chakravarti, Shukti ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

CD14; dextran sodium sulfate; extracellular matrix; inflammation; innate immune response; lumican; murine colitis; neutrophils; TLR4; tri nitrobenzene sulfonic acid

Indexed keywords

CXCL1 CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; LUMICAN; SCLEROPROTEIN; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLITIS; COLON; CONTROLLED STUDY; FEMALE; GENE CONTROL; INNATE IMMUNITY; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

ANIMALS; BLOTTING, WESTERN; CHONDROITIN SULFATE PROTEOGLYCANS; COLITIS; CYTOKINES; DISEASE MODELS, ANIMAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; FLOW CYTOMETRY; HAPTENS; INFLAMMATION; KERATAN SULFATE; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; TOLL-LIKE RECEPTOR 4; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 83555161650     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21713     Document Type: Article

References (37)

1. Kaser A, Zeissig S, Blumberg RS,. Inflammatory bowel disease. Annu Rev Immunol. 2010; 28: 573-621.
2. Podolsky DK,. Inflammatory bowel disease. N Engl J Med. 2002; 347: 417-429. (Pubitemid 34851835)
3. Danese S, Fiocchi C,. Etiopathogenesis of inflammatory bowel diseases. World J Gastroenterol. 2006; 12: 4807-4812. (Pubitemid 44323204)
4. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001; 411: 603-606. (Pubitemid 32531409)
5. Strober W, Fuss I, Mannon P,. The fundamental basis of inflammatory bowel disease. J Clin Invest. 2007; 117: 514-521. (Pubitemid 46348505)
6. Kawai T, Akira S,. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010; 11: 373-384.
7. Karin M,. The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation. J Biol Chem. 1999; 274: 27339-27342.
8. Sen R, Smale ST,. Selectivity of the NF-{kappa}B response. Cold Spring Harb Perspect Biol. 2010; 2: a000257.
9. Jiang D, Liang J, Fan J, et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med. 2005; 11: 1173-1179. (Pubitemid 43093664)
10. Schaefer L, Babelova A, Kiss E, et al. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest. 2005; 115: 2223-2233. (Pubitemid 41134165)
11. He YW, Li H, Zhang J, et al. The extracellular matrix protein mindin is a pattern-recognition molecule for microbial pathogens. Nat Immunol. 2004; 5: 88-97. (Pubitemid 38081473)
12. Lawrance IC, Wu F, Leite AZ, et al. A murine model of chronic inflammation-induced intestinal fibrosis down-regulated by antisense NF-kappa B. Gastroenterology. 2003; 125: 1750-1761. (Pubitemid 37500440)
13. Wu F, Chakravarti S,. Differential expression of inflammatory and fibrogenic genes and their regulation by NF-{kappa}B inhibition in a mouse model of chronic colitis. J Immunol. 2007; 179: 6988-7000.
14. Wu F, Vij N, Roberts L, et al. A novel role of the lumican core protein in bacterial lipopolysaccharide-induced innate immune response. J Biol Chem. 2007; 282: 26409-26417. (Pubitemid 47443780)
15. Chakravarti S, Magnuson T, Lass JH, et al. Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J Cell Biol. 1998; 141: 1277-1286. (Pubitemid 28265620)
16. Neurath M, Fuss I, Strober W,. TNBS-colitis. Int Rev Immunol. 2000; 19: 51-62. (Pubitemid 30146942)
17. Mombaerts P, Iacomini J, Johnson RS, et al. RAG-1-deficient mice have no mature B and T lymphocytes. Cell. 1992; 68: 869-877.
18. Pavlick KP, Ostanin DV, Furr KL, et al. Role of T-cell-associated lymphocyte function-associated antigen-1 in the pathogenesis of experimental colitis. Int Immunol. 2006; 18: 389-398. (Pubitemid 43160151)
19. Chakravarti S,. Functions of lumican and fibromodulin: lessons from knockout mice. Glycoconj J. 2002; 19: 287-293. (Pubitemid 37174557)
20. Chakravarti S, Stallings RL, SundarRaj N, et al. Primary structure of human lumican (keratan sulfate proteoglycan) and localization of the gene (LUM) to chromosome 12q21.3-q22. Genomics. 1995; 27: 481-488.
21. Lee S, Bowrin K, Hamad AR, et al. Extracellular matrix lumican deposited on the surface of neutrophils promotes migration by binding to beta2 integrin. J Biol Chem. 2009; 284: 23662-23669.
22. Saika S, Shiraishi A, Liu CY, et al. Role of lumican in the corneal epithelium during wound healing. J Biol Chem. 2000; 275: 2607-2612. (Pubitemid 30082027)
23. Vij N, Roberts L, Joyce S, et al. Lumican suppresses cell proliferation and aids Fas-Fas ligand mediated apoptosis: implications in the cornea. Exp Eye Res. 2004; 78: 957-971. (Pubitemid 38402204)
24. Vij N, Roberts L, Joyce S, et al. Lumican regulates corneal inflammatory responses by modulating Fas-Fas ligand signaling. Invest Ophthalmol Vis Sci. 2005; 46: 88-95. (Pubitemid 40041183)
25. Neurath MF, Becker C, Barbulescu K,. Role of NF-kappaB in immune and inflammatory responses in the gut. Gut. 1998; 43: 856-860. (Pubitemid 28539668)
26. Neurath MF, Pettersson S, Meyer zum Buschenfelde KH, et al. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med. 1996; 2: 998-1004. (Pubitemid 26306838)
27. Yamada Y, Marshall S, Specian RD, et al. A comparative analysis of two models of colitis in rats. Gastroenterology. 1992; 102: 1524-1534.
28. Neurath M, Fuss I, Kelsall B, et al. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med. 1995; 182: 1281-1290.
29. Sainathan SK, Hanna EM, Gong Q, et al. Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis. Inflamm Bowel Dis. 2008; 14: 88-99. (Pubitemid 351196873)
30. Fukata M, Michelsen KS, Eri R, et al. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am J Physiol Gastrointest Liver Physiol. 2005; 288: G1055-1065. (Pubitemid 40563149)
31. Gibson DL, Ma C, Bergstrom KS, et al. MyD88 signalling plays a critical role in host defence by controlling pathogen burden and promoting epithelial cell homeostasis during Citrobacter rodentium-induced colitis. Cell Microbiol. 2008; 10: 618-631. (Pubitemid 351194091)
32. Abreu MT, Fukata M, Arditi M,. TLR signaling in the gut in health and disease. J Immunol. 2005; 174: 4453-4460.
33. Rakoff-Nahoum S, Hao L, Medzhitov R,. Role of Toll-like receptors in spontaneous commensal-dependent colitis. Immunity. 2006; 25: 319-329. (Pubitemid 44224143)
34. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell. 2004; 118: 229-241. (Pubitemid 38962578)
35. Yamamoto-Furusho JK, Podolsky DK,. Innate immunity in inflammatory bowel disease. World J Gastroenterol. 2007; 13: 5577-5580. (Pubitemid 350031477)
36. Ruoslahti E, Yamaguchi Y, Hildebrand A, et al. Extracellular matrix/growth factor interactions. Cold Spring Harb Symp Quant Biol. 1992; 57: 309-315.
37. Beattie J, McIntosh L, van der Walle CF,. Cross-talk between the insulin-like growth factor (IGF) axis and membrane integrins to regulate cell physiology. J Cell Physiol. 2010; 224: 605-611.